Insights into how H19 works in glioma cells. A review article
Glioblastoma is a highly aggressive brain tumor and considered to be the most common primary one. Recurrence after treatment is a significant problem, with a survival rate after one year of about 39.7%. The recurrence of GBM is linked to different cellular pathways and molecular signaling. Long non-...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2021-01-01
|
| Edice: | Cancer Treatment and Research Communications |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S246829422100109X |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
